September 15, 2022
Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V:ZEN an intellectual property development and commercialization company, reports, further to its press release dated April 11, 2022, that it has received the final report from Phase 1 testing under its Innovation Solutions Canada (“ISC”) Testing Stream contract, which notes that all Phase 1 targets were met including: (i) a sufficient reduction in live airborne test organisms without modification to existing HVAC systems, (ii) no reduction in air flow rates, and (iii) no significant shedding of the ZenGUARD™ coating. ZenGUARD™-coated HVAC filters demonstrated a maximum improvement of 99% compared to equivalent MERV-rated uncoated filters using a bacteriophage (a SARS-COV-2 surrogate).
“The significant increase in filtration efficiency of pathogen-laden water droplets, without an impact to airflow rates, creates a potentially powerful solution in the HVAC space,” said Greg Fenton, CEO of Zentek. “Working with current systems, and not requiring additional energy or changes to existing equipment, our technology could be a simple and energy-efficient approach to providing cleaner air for indoor spaces and is highly supportive of current global indoor air quality initiatives.”
Phase 1 testing was conducted by CremCo Laboratories with assistance by the Aerospace Research Centre, a department of the National Research Council of Canada. Zentek is now in Phase 2 Testing at the National Research Council to demonstrate a reduction in live airborne surrogate contamination within a modular classroom environment, simulating a real-world environment. The Company will report results when completed and validated.
About Zentek Ltd.
Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.
Zentek’s proprietary ZenGUARD™ coating is patent-pending and shown to have 99% antimicrobial activity, including against COVID-19, for use in PPE and potentially HVAC systems and other industries. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.
For further information:
Tyler Dunn?
Tel: (306) 717-6745?
Email: tdunn@zentek.com
Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V:ZEN an intellectual property development and commercialization company, reports, further to its press release dated April 11, 2022, that it has received the final report from Phase 1 testing under its Innovation Solutions Canada (“ISC”) Testing Stream contract, which notes that all Phase 1 targets were met including: (i) a sufficient reduction in live airborne test organisms without modification to existing HVAC systems, (ii) no reduction in air flow rates, and (iii) no significant shedding of the ZenGUARD™ coating. ZenGUARD™-coated HVAC filters demonstrated a maximum improvement of 99% compared to equivalent MERV-rated uncoated filters using a bacteriophage (a SARS-COV-2 surrogate).
“The significant increase in filtration efficiency of pathogen-laden water droplets, without an impact to airflow rates, creates a potentially powerful solution in the HVAC space,” said Greg Fenton, CEO of Zentek. “Working with current systems, and not requiring additional energy or changes to existing equipment, our technology could be a simple and energy-efficient approach to providing cleaner air for indoor spaces and is highly supportive of current global indoor air quality initiatives.”
Phase 1 testing was conducted by CremCo Laboratories with assistance by the Aerospace Research Centre, a department of the National Research Council of Canada. Zentek is now in Phase 2 Testing at the National Research Council to demonstrate a reduction in live airborne surrogate contamination within a modular classroom environment, simulating a real-world environment. The Company will report results when completed and validated.
About Zentek Ltd.
Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.
Zentek’s proprietary ZenGUARD™ coating is patent-pending and shown to have 99% antimicrobial activity, including against COVID-19, for use in PPE and potentially HVAC systems and other industries. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.
For further information:
Tyler Dunn?
Tel: (306) 717-6745?
Email: tdunn@zentek.com
Recent ZTEK News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2026 01:50:43 PM
- Zentek's ZenGUARD(TM) Enhanced Air Filters Now Available for Direct Procurement by All Federal Departments and Agencies • Newsfile • 05/13/2026 11:35:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/06/2026 05:21:02 PM
- Zentek Accepting Canadian Commercial Orders for ZenGUARD(TM) Enhanced Air Filters Following Health Canada Regulatory Classification • Newsfile • 05/06/2026 04:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2026 02:01:22 PM
- Albany Graphite Launches Year Two Environmental and Social Baseline Program with ERM and Constance Lake First Nation • Newsfile • 04/28/2026 11:33:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/22/2026 02:21:13 PM
- Albany Graphite Executes Agreement with AETC for Certified Samples and Process Engineering, Completing the Set of Three Independent Workstreams Feeding the PEA • Newsfile • 04/21/2026 11:57:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/16/2026 08:20:27 PM
- Albany Graphite Corp. Engages AppEco for Independent Market Research and Economic Analysis • Newsfile • 04/16/2026 02:55:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2026 06:01:49 PM
- Triera Biosciences Completes Innovative Solutions Canada Contract, Advances Platform Toward New Candidate Development • Newsfile • 04/14/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/13/2026 02:06:25 PM
- Albany Graphite Corp. Engages Micon International to Complete New PEA for Albany Graphite Project • Newsfile • 04/09/2026 01:20:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/01/2026 02:08:37 PM
- Zentek Engages ICP Securities Inc. for Automated Market Making Services • Newsfile • 04/01/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2026 02:37:13 PM
- Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification • ACCESS Newswire • 03/25/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/13/2026 02:33:34 PM
- Zentek Ltd. Receives Favorable Judgment in Long-Standing Litigation • ACCESS Newswire • 03/13/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/09/2026 08:55:20 PM
- Zentek Provides PDAC 2026 Update - Government and First Nations Engagement • ACCESS Newswire • 03/09/2026 08:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2026 03:50:24 PM
- Zentek Announces Pilot Evaluation Program with Quality Filters Inc. • ACCESS Newswire • 03/04/2026 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2026 10:19:17 PM
